Center For Scientific Review; Notice of Closed Meetings, 77166-77167 [2024-21501]

Download as PDF 77166 Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review of Mentoring Network (UE5), DSR Member-Conflict (K), and Conference (R13) Grant Applications. Date: October 29, 2024. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Dental & Craniofacial Research 31 Center Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jingshan Chen, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, National Institute of Dental & Craniofacial Research, 31 Center Drive, Bethesda, MD 20892 (301) 451–2405 email: jingshan.chen@ nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review of Clinical Study Applications. Date: October 30, 2024. Time: 12:00 p.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Dental & Craniofacial Research 31 Center Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Yun Mei, MD Scientific Review Officer Scientific Review Branch National Institute of Dental & Craniofacial Research National Institutes of Health 31 Center Drive Bethesda, MD 20892 (301) 827– 4639 email: yun.mei@nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Biodata Management and Analysis Study Section. Date: October 17–18, 2024. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: E. Bryan Crenshaw, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480–7129, bryan.crenshaw@ nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Lifestyle and Health Behaviors Study Section. Date: October 17–18, 2024. Time: 9:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: AC Hotel, 4646 Montgomery Ave., Bethesda, MD 20814. Contact Person: Jewel L Wright, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827–9038, jewel.wright@nih.gov. Name of Committee: Oncology 1—Basic Translational Integrated Review Group; Tumor Host Interactions Study Section. Date: October 17–18, 2024. Time: 9:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Angela Y Ng, Ph.D., MBA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 710–C, MSC 7806, Bethesda, MD 20892, (301) 435– 1715, nga@csr.nih.gov. Name of Committee: Emerging Technologies and Training Neurosciences Integrated Review Group; Imaging Technology for Neuroscience Study Section. Date: October 21–22, 2024. Time: 7:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Dated: September 17, 2024. Bruce A. George, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–21589 Filed 9–19–24; 8:45 am] ddrumheller on DSK120RN23PROD with NOTICES1 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as VerDate Sep<11>2014 16:44 Sep 19, 2024 Jkt 262001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 Contact Person: Rachel A Kane, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Bethesda, MD 20892, (301) 496–0221, kanera@csr.nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Clinical Oncology Study Section. Date: October 21–22, 2024 Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: The Watergate, 2650 Virginia Avenue NW, Washington, DC 20037. Contact Person: Laura Asnaghi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockville Drive, Room 6200, MSC 7804 Bethesda, MD 20892, (301) 443– 1196, laura.asnaghi@nih.gov. Name of Committee: Applied Immunology and Disease Control Integrated Review Group; Interspecies Microbial Interactions and Infectious Study Section. Date: October 21, 2024. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites Alexandria Old Town, 1900 Diagonal Road, Alexandria, VA 22314. Contact Person: Subhamoy Pal, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–0926, subhamoy.pal@ nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genetics of Health and Disease Study Section. Date: October 21–22, 2024. Time: 9:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Christopher Payne, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm. 2208, Bethesda, MD 20892, 301–402–3702 christopher.payne@nih.gov. Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Neurotoxicology and Alcohol Study Section. Date: October 21–22, 2024. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Eileen Marie Moore, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–8928, eileen.moore@ nih.gov. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Clinical Management in General Care Settings Study Section. Date: October 21–22, 2024. E:\FR\FM\20SEN1.SGM 20SEN1 Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852. Contact Person: Jessica Campbell Chambers, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496–5693, jessica.chambers@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 16, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–21501 Filed 9–19–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2024–0781] National Chemical Transportation Safety Advisory Committee; October 2024 Meeting Coast Guard, Department of Homeland Security. ACTION: Notice of open Federal advisory committee meetings. AGENCY: The National Chemical Transportation Safety Advisory Committee (Committee) and its three subcommittees will meet in public in Washington, DC to discuss matters relating to the safe and secure marine transportation of hazardous materials. The Committee will be held in person only. The three subcommittee meetings will be virtual. For more detailed information regarding the subcommittee meetings, see Agenda Day 1 and Day 2 below. DATES: Four Open Meetings: (1) The Support Reductions to Emissions and Environmental Impacts Associated with Marine Transport of Chemicals, Liquefied Gases and Liquefied Natural Gas (LNG); Including the Working Group on the update to 46 CFR 150 concerning Cargo Compatibility Testing subcommittee will meet virtually on Tuesday, October 8, 2024, from 2 p.m. to 5 p.m. Eastern Daylight Time (EDT). If the subcommittee has completed its business the meeting may end early. (2) The Industry Best Practices and Regulatory Updates Related to the ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 16:44 Sep 19, 2024 Jkt 262001 Maritime Transportation of Lithium Batteries subcommittee will meet virtually on Wednesday, October 9, 2024, from 9 a.m. to noon EDT. If the subcommittee has completed its business the meeting may end early. (3) The Updates to CG–ENG Policy Letter 02–15: Design Standards For U.S. Barges Intending to Carry Liquefied Natural Gas in Bulk subcommittee will meet virtually on Wednesday, October 9, 2024, from 1:30 p.m. to 5 p.m. EDT. If the subcommittee has completed its business the meeting may end early. (4) The National Chemical Transportation Safety Advisory Committee will meet in-person on Thursday, October 10, 2024, from 9 a.m. to 2 p.m. EDT. If the Committee has completed its business the meeting may end early. The subcommittee taskings and other subcommittee information can be found using the following address: https:// homeport.uscg.mil/missions/federaladvisory-committees/national-chemicaltransportation-safety-advisorycommittee-(nctsac)/task-statements. Comments and supporting documents: To ensure your comments are received by Committee and subcommittee members before the meetings, submit your written comments no later than September 24, 2024. Please specify to whom your comments are directed: the Committee or the subcommittees. ADDRESSES: The National Chemical Transportation Safety Advisory Committee meeting will be held at the American Bureau of Shipping Group, 80 M Street Southeast, Suite 480, Washington, DC 20003. Pre-registration Information: Preregistration is required for in-person access to the full Committee meeting or to attend the subcommittee meetings via videoconference. Public attendees will be required to pre-register no later than noon EDT on September 24, 2024, to be admitted to the meetings. In-person attendance may be capped due to limited space in the meeting venue, and registration will be on a first-come-firstserved basis. To pre-register, contact Lieutenant Joseph Kolb at Joseph.B.Kolb2@uscg.mil. You will be asked to provide your name, telephone number, email, company or group with which you are affiliated, and whether you wish to attend virtually for subcommittee meetings or in person for full Committee meeting. If you wish to attend virtually, please also provide the subcommittee meeting(s) you wish to attend. The National Chemical Transportation Safety Advisory Committee is committed to ensuring all PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 77167 participants have equal access regardless of disability status. If you require reasonable accommodation due to a disability to fully participate, please email Lieutenant Joseph Kolb at Joseph.B.Kolb2@uscg.mil or call at 206– 815–1623 as soon as possible. Instructions: You are free to submit comments at any time, including orally at the meetings as time permits, but if you want Committee or subcommittee members to review your comment before the meetings, please submit your comments no later than September 24, 2024. We are particularly interested in comments on the topics in the ‘‘Agenda’’ section below. We encourage you to submit comments through the Federal Decision Making Portal at https://www.regulations.gov. To do so, go to https://www.regulations.gov, type USCG–2024–0781 in the search box, and click ‘‘Search’’. Next, look for this document in the Search Results column and click on it. Then click on the Comment option. If your material cannot be submitted using https:// www.regulations.gov, contact the individual in the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. You must include the docket number [USCG–2024–0781]. Comments received will be posted without alteration at https://www.regulations.gov, including any personal information provided. You may wish to review the Privacy and Security Notice found via a link on the homepage of https:// www.regulations.gov, and the Department of Homeland Security’s eRulemaking System of Records notice (85 FR 14226, March 11, 2020). If you encounter technical difficulties with comment submission, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this notice. Docket Search: Documents mentioned in this notice as being available in the docket, and all public comments, will be in the online docket at https:// www.regulations.gov and can be viewed by following that website’s instructions. Additionally, if you go to the online docket and sign-up for email alerts, you will be notified when comments are posted. FOR FURTHER INFORMATION CONTACT: Lieutenant Joseph Kolb, Alternate Designated Federal Officer of the National Chemical Transportation Safety Advisory Committee, telephone 206–815–1623, or email Joseph.B.Kolb2@uscg.mil. SUPPLEMENTARY INFORMATION: Notice of these meetings is in compliance with the Federal Advisory Committee Act, E:\FR\FM\20SEN1.SGM 20SEN1

Agencies

[Federal Register Volume 89, Number 183 (Friday, September 20, 2024)]
[Notices]
[Pages 77166-77167]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21501]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center For Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Bioengineering Sciences & Technologies 
Integrated Review Group; Biodata Management and Analysis Study 
Section.
    Date: October 17-18, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: E. Bryan Crenshaw, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-7129, 
[email protected].

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Lifestyle and Health Behaviors Study 
Section.
    Date: October 17-18, 2024.
    Time: 9:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: AC Hotel, 4646 Montgomery Ave., Bethesda, MD 20814.
    Contact Person: Jewel L Wright, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-9038, 
[email protected].

    Name of Committee: Oncology 1--Basic Translational Integrated 
Review Group; Tumor Host Interactions Study Section.
    Date: October 17-18, 2024.
    Time: 9:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Angela Y Ng, Ph.D., MBA, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 710-C, MSC 7806, Bethesda, MD 
20892, (301) 435-1715, [email protected].

    Name of Committee: Emerging Technologies and Training 
Neurosciences Integrated Review Group; Imaging Technology for 
Neuroscience Study Section.
    Date: October 21-22, 2024.
    Time: 7:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 
22102.
    Contact Person: Rachel A Kane, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Dr., Bethesda, MD 20892, (301) 496-0221, 
[email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Clinical Oncology Study Section.
    Date: October 21-22, 2024
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Watergate, 2650 Virginia Avenue NW, Washington, DC 
20037.
    Contact Person: Laura Asnaghi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockville Drive, Room 6200, MSC 7804 Bethesda, MD 20892, (301) 443-
1196, [email protected].

    Name of Committee: Applied Immunology and Disease Control 
Integrated Review Group; Interspecies Microbial Interactions and 
Infectious Study Section.
    Date: October 21, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites Alexandria Old Town, 1900 Diagonal Road, 
Alexandria, VA 22314.
    Contact Person: Subhamoy Pal, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 594-0926, 
[email protected].

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Genetics of Health and Disease Study Section.
    Date: October 21-22, 2024.
    Time: 9:00 a.m. to 9:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Christopher Payne, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Rm. 2208, Bethesda, MD 20892, 301-402-
3702 [email protected].

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group; Neurotoxicology and Alcohol 
Study Section.
    Date: October 21-22, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Eileen Marie Moore, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-8928, 
[email protected].

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Clinical Management in General Care 
Settings Study Section.
    Date: October 21-22, 2024.

[[Page 77167]]

    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 
20852.
    Contact Person: Jessica Campbell Chambers, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-5693, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: September 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-21501 Filed 9-19-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.